Novartis's shift into high-tech drugs won praise for giving new options to patients but criticism for prices that may run into the millions of ...
ZURICH: Novartis's shift into high-tech drugs won praise for giving new options to patients but criticism for prices that may run into the millions of dollars as the Swiss drugmaker faced investors at its annual general meeting on Thursday.
Swiss shareholder group Actares, which owns a small percentage of Novartis shares, said insurance systems are being"taken hostage" by high prices for life-saving drugs. Chief Executive Vas Narasimhan said he seeks to price medicines based on the value they provide and that the company needs a fair return to continue research.Shareholders were also due to vote on Novartis's planned spin-off of its Alcon eyecare unit.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novartis licenses rights to RNA-targeting cardio drug from IonisSwiss drugmaker Novartis said on Monday it is exercising its option to license rights to an investigational, RNA-targeting cardiovascular drug ...
Read more »
US senators tell drug company executives pricing is 'morally repugnant'Seven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a ...
Read more »
Senators tell drug company executives pricing is 'morally repugnant'Seven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a ...
Read more »
Pharma stocks could see turbulence from US Senate drug-price hearingU.S. healthcare stocks could face more turbulence on Tuesday, after a bumpy early 2019, as top executives from some of the largest pharmaceutical ...
Read more »
Buffett appears to fault Trump, laments M&A dearth in Berkshire shareholder letterWarren Buffett on Saturday appeared to fault U.S. President Donald Trump for taking too much credit for the nation's economic growth, while ...
Read more »
Top Bristol-Myers shareholder comes out against US$74 billion Celgene dealBristol-Myers Squibb Co's top shareholder Wellington Management said on Wednesday that it did not support the U.S. drugmaker's US$74 billion ...
Read more »
Embraer shareholders OK sale of commercial jet division to BoeingA federal court in Brazil has lifted an injunction that had prohibited Embraer SA from holding a shareholders' meeting to approve a tie-up with ...
Read more »